Trial · NCT02591862
Results by group72
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 72
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Measurement of Ratio of LDH to the Upper Limit of Normal (ULN) | Coversin | Day 0 | 5.6 | Ratio of LDH:ULN (250 U/L) | |
| Measurement of Ratio of LDH to the Upper Limit of Normal (ULN) | Coversin | Day 28 | 1.9 | Ratio of LDH:ULN (250 U/L) | |
| Number and Type of Adverse Events (AE) | Coversin | Serious Adverse Events (SAE) | 2 | Events | |
| Number and Type of Adverse Events (AE) | Coversin | Adverse Event (AE) (total) | 20 | Events | |
| Number and Type of Adverse Events (AE) | Coversin | Treatment Emergent Adverse Event (TAEA) | 13 | Events | |
| Number and Type of Adverse Events (AE) | Coversin | AE - moderate | 1 | Events | |
| Number and Type of Adverse Events (AE) | Coversin | AE - severe | 1 | Events | |
| Number and Type of Adverse Events (AE) | Coversin | AE- mild | 18 | Events | |
| Measurement of Haemoglobin (Hb) at Days 28, 90, and 180, Absolute and Change From Baseline | Coversin | Baseline | 8.2 | millimole(s)/litre | |
| Measurement of Haemoglobin (Hb) at Days 28, 90, and 180, Absolute and Change From Baseline | Coversin | Day 28 (absolute) | 7.8 | millimole(s)/litre | |
| Measurement of Haemoglobin (Hb) at Days 28, 90, and 180, Absolute and Change From Baseline | Coversin | Day 28 (change from baseline) | -0.7 | millimole(s)/litre | |
| Measurement of Haemoglobin (Hb) at Days 28, 90, and 180, Absolute and Change From Baseline | Coversin | Day 90 (absolute) | 7.8 | millimole(s)/litre | |
| Measurement of Haemoglobin (Hb) at Days 28, 90, and 180, Absolute and Change From Baseline | Coversin | Day 90 (change from baseline) | -0.4 | millimole(s)/litre | |
| Measurement of Haemoglobin (Hb) at Days 28, 90, and 180, Absolute and Change From Baseline | Coversin | Day 180 (absolute) | 8.0 | millimole(s)/litre | |
| Measurement of Haemoglobin (Hb) at Days 28, 90, and 180, Absolute and Change From Baseline | Coversin | Day 180 (change from baseline) | -0.2 | millimole(s)/litre | |
| Measurement of Haptoglobin (Hp) at Days 28, 90 and 180, Absolute and Change From Baseline | Coversin | Baseline | NA | gram(s)/litre | |
| Measurement of Haptoglobin (Hp) at Days 28, 90 and 180, Absolute and Change From Baseline | Coversin | Day 28 | NA | gram(s)/litre | |
| Measurement of Haptoglobin (Hp) at Days 28, 90 and 180, Absolute and Change From Baseline | Coversin | Day 90 | NA | gram(s)/litre | |
| Measurement of Haptoglobin (Hp) at Days 28, 90 and 180, Absolute and Change From Baseline | Coversin | Day 180 | NA | gram(s)/litre | |
| Measurement of Lactate Dehydrogenase (LDH) at Baseline, Day 90 and Day 180 | Coversin | Day 0 | 5.6 | Ratio of LDH:ULN (250 U/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02591862/results